slides · global inventory
Testimonial
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 3,034
Current window 1,771-1,800
Pages 102
Rows per page 30
Slide type
1,771-1,800 of 3,034
266
The slide highlights the physician's self-proclaimed influence and his personal relationship with sales reps, potentially exposing aggressive marketing tactics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
267
The slide uses highlighted text to emphasize aggressive prescribing behavior and high patient penetration rates.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
268
The slide uses highlighted text to emphasize the doctor's skepticism regarding the drug's 'game-changer' status and the saturation of his patient base.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
273
The slide uses a Q&A transcript format to validate the summary points provided at the top.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
275
The slide uses direct quotes from a consultation call to challenge the drug's safety and efficacy profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
276
The slide contrasts the prescriber's relaxed attitude toward cardiac/hepatic monitoring with a specific, concerning anecdote about a patient experiencing uncontrollable anger.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
279
The slide highlights key negative sentiment regarding market saturation and physician adoption hurdles.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
281
The slide presents a transcript of an interview with a physician, highlighting negative clinical experience.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
282
The slide uses bolding and highlighting to emphasize negative sentiment from a key opinion leader.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
283
The slide uses a Q&A format to highlight a specific adverse event and the resulting loss of confidence in the drug's safety profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
285
The slide uses a Q&A transcript format to detail a specific medical case study involving drug safety concerns.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
286
The slide highlights a potential safety concern and a perceived lack of transparency or concern from the manufacturer's sales representative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
292
The slide uses direct quotes to expose a contradiction between the company's marketing (non-controlled status) and the actual physician experience (high administrative burden).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
293
The slide uses highlighted text to emphasize key negative sentiments from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
318
The slide uses direct quotes to expose potential unethical sales practices and reliance on key opinion leaders (KOLs) in the pharmaceutical industry.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
358
The slide uses direct quotes from former employees to validate the thesis of market saturation and internal company struggles.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
360
Includes verbatim interview transcripts highlighting the 'crash' after initial launch spikes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
361
The slide uses highlighted text to emphasize key claims about PIPs and quota misalignment.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
362
The slide uses direct quotes from ex-managers to highlight a shift in company culture towards aggressive performance management.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
363
The slide uses a Q&A format to validate the thesis of a slowing business.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
364
The slide uses direct quotes from a KOL to contradict the company's narrative of market growth.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
365
The slide uses direct Q&A transcripts to validate the thesis that the product has hit a growth ceiling.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
116
The slide presents qualitative evidence of product reliability issues through field engineer interviews.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
118
The slide presents a Q&A style interview excerpt highlighting product reliability issues and the scale of support staff required.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
128
The slide uses direct quotes to frame Lasertec as unreliable and unsuitable for production, positioning KLA as the desired alternative.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
154
The slide presents a Q&A format to highlight technical failures in a competitor's product.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
190
The slide uses a Q&A format to highlight specific pain points (performance, uptime, cost) experienced by major semiconductor manufacturers.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
200
The slide presents a Q&A format to expose operational issues and toxic workplace behavior linked to equipment failure.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
213
The slide highlights a specific competitive disadvantage for Lasertec regarding light source efficiency and market share loss at TSMC.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
215
The slide presents a Q&A format to expose a gap in product-market fit for Lasertec's equipment in high-volume production environments.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit